FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 The Copaxone News Channel
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week
March 2005   
June 2005   
July 2005   
August 2005   
October 2005   
November 2005   
December 2005   
January 2006   
February 2006   
May 2006   
June 2006   
August 2006   
October 2006   
November 2006   
December 2008   
January 2013   
May 2013   
June 2013   
July 2013   
September 2013   
October 2013   
November 2013   
November 2014   
December 2014   
January 2015   
March 2015   
April 2015   
May 2015   
July 2015   
February 2016   

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

ARE TAPEWORMS THE CONCEPTUAL KEY TO THE NEXT MS BLOCKBUSTER DRUG?

Summary

The "Old Friends Hypothesis" theorizes that the cause of autoimmune disorders is that humans evolved with intestinal parasites, which suppressed the immune system to survive in humans.

With that natural immune suppression now gone, the immune system is unleashed and dangerous. MS, also an autoimmune disease, is virtually nonexistent in Africa, where parasites still thrive in humans.

MS is twice as prevalent in women than men, perhaps because the female immune system evolved under double suppression of pregnancy to prevent immune attacks on the fetus.

With pregnancy controlled and parasites gone, women's immune systems may be doubly unleashed, which may account for the double incidence of MS in women over men.

SYN is testing pregnancy hormone estriol together with immunosuppresant MS blockbuster Copaxone for synergistic interaction. Phase 2 results due on April 29. If successful, it may piggyback off Copaxone sales.

Pathogenic infections are understandable. A foreign organism invades your body and you get sick. The immune system eventually takes care of it, sometimes with the help of other drugs. Autoimmune disorders, on the other hand, are much more frustrating. Why would your body suddenly start attacking itself? How would you even theoretically go about preventing such a thing?

In most cases autoimmune diseases are painful nuisances that can be managed. The autoimmune disease with the highest prevalence is Graves disease (page 11), which is when immune cells make the thyroid basically go berserk, speeding up the body's metabolism into turbo overdrive. The only way to manage it is to kill the thyroid gland and take supplemental thyroxin instead. The second most common is rheumatoid arthritis at around 1% of the global population (link above). Here the immune system attacks joints, destroying them and making it painful and difficult to move. The only long term treatment available is immune suppression.

Story Source: The above story is based on materials provided by SEEKING ALPHA
Note: Materials may be edited for content and length